HealthdirectFree Australian health advice you can count on.

( ARTG ) Celestone Chronodose is indicated in the treatment of both severe and moderate conditions in acute and chronic self-limiting diseases responsive to systemic corticosteroid therapy and is especially useful in patients for whom treatment with oral corticosteroid medication is not feasible.‍‍‍‍‍‍​​​‍​​​​​​ Representative conditions: Rheumatic Disorders: rheumatoid arthritis, acute and subacute bursitis, epicondylitis, acute non-specific tenosynovitis, myositis, fibrositis, tendonitis, psoriatic arthritis. Collagen Diseases: systemic lupus erythematosus, scleroderma, dermatomyositis. Allergic States: status asthmaticus, chronic bronchial asthma, seasonal or perennial allergic rhinitis, severe allergic bronchitis, contact dermatitis, atopic dermatitis, hypersensitivity reactions to drug and insect bites. Dermatologic Conditions: localised, hypertrophic infiltrated lesions of lichen planus, psoriatic plaques, granuloma annulare and lichen simplex chronicus(neurodermatitis). keloids, discoid lupus erythematosus, necrobiosis lipoidica diabeticorum, alopecia areata. Antepartum use in the prevention of respiratory distress syndrome in premature infants when it is deemed necessary to induce labour prior to the thirty-second week of gestation becomes inevitable because of obstetric complication. Celestone Chronodose injection should also be considered for prophylactic treatment if the foetus is known to have a low lecithin/sphingomyelin ratio (or decreased foam stability test on amniotic fluid).